• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Veramed Limited, Twickenham, UK, United Kingdom

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 1 of 1

  • Page:
  • 1

Efficacy and Safety of Fremanezumab for the Preventive Treatment of Episodic and Chronic Migraine in Children and Adolescents: Outcomes from Two Randomized, Double-blind, Placebo-controlled, Phase 3 Studies

Author:Hershey, Andrew   Szperka, Christina   Barbanti, Piero   Pozo-Rosich, Patricia   Li, Thomas   Collins, Suzy-Erin   Bryson, Juline   Kessler, Yoel   Carmeli Schwartz, Yael   Ramirez Campos, Verena   Ning, Xiaoping   

Session Name:S37: Headache Clinical Trials  

Topic:Headache  

Program Number:S37.003  

Author Institution:Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA, OH  Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA  Headache and Pain Unit, IRCCS San Raffaele and San Raffaele University, Rome, Italy, Rome, Italy  Headache Unit and Research Group, Vall d’Hebron Hospital and Research Institute, Universitat Autonoma de Barcelona, Barcelona, Spain, Barcelona, Spain  Teva Pharmaceutical Industries Ltd, Tel Aviv, Israel, Israel  Veramed Limited, Twickenham, UK, United Kingdom  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA, West Chester, PA  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA, PA  

  • View Abstract
  • View Disclosure

Displaying 1 - 1 of 1

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com